Dr Joseph  Sliman, MD, MPH

Dr Joseph Sliman, MD, MPH



Joseph A. Sliman, MD, MPH, Senior Vice President, Clinical & Regulatory Affairs, Synthetic Biologics, Inc. a biotechnology company developing novel anti-infective biologics and drugs targeting specific pathogens that cause serious infections and diseases. Presentation Topic: "Oral Enzyme Therapy to Protect the Gut Microbiome from the Harmful Effects of IV Antibiotics for the Prevention of Clostridium difficile Infection (CDI)